Fortitude Family Office’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VFM
Fortitude Family Office's BMY Position: Q3 2026 in Review
Fortitude Family Office increased its Bristol-Myers Squibb (BMY) stake by 20% in Q3 2026, buying an estimated $15.5K and bringing the position to 1,451 shares worth $90.5K. The position accounts for 0.02% of the portfolio, ranked #285.
Fortitude Family Office first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $540K in Q4 2024. 340 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Fortitude Family Office held 1,451 shares of Bristol-Myers Squibb worth $90.5K as of Q3 2026.
- Fortitude Family Office bought 246 Bristol-Myers Squibb shares in Q3 2026, an estimated $15.5K.
- Bristol-Myers Squibb made up 0.02% of Fortitude Family Office's portfolio in Q3 2026, its #285 holding.
- Fortitude Family Office first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- Fortitude Family Office's Bristol-Myers Squibb position peaked at $540K in Q4 2024.
- 340 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.